D.Pharm, B.Pharm with minimum 2 years of post- qualification experience in retail pharmacy. Retail Business Division of HLL Lifecare Limited is setting up new Amrit Pharmacy outlet at Government RDBP Jaipuria Hospital, Jaipur, Rajasthan for which the company is looking for dynamic and performance driven professionals with the right attitude.
Development of Electrolyzer Technologies For Affordable Generation of Hydrogen. Master, Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences
Fresenius Kabi India is a global healthcare company MNC) that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically & chronically ill patients.
Having experience in Injectable - IQ, OQ, PQ of process equipment,utilities, lab equipment and Instrument, Sops, Protocal preparation,execution, Compilation and report prepartion.
Hands on Experience in IPQA Manufacturing process and Engineering IPQA, AQA Micro, Documentation, Validations, Stability Management and Document review.
To file amendments and deficiency response within timelines with go getter approach. The job requires review of documents related to DMF submission against predefined checklists and submission to various agencies globally.
Ensure submission and approval of high-quality regulatory applications within planned timelines and Facilitate interactions with regulatory bodies on a regular basis for approvals.
National pharmaceuticals pricing authority asked pharmaceutical industries to reduce prices of anticancer medicines post declining custom duty to zero. The government reduced custom duty on three Anti-cancer medicines namely, Trastuzumab Deruxtecan, Osimertinib and Durvalumab.
Researchers at the University of Copenhagen have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other inflammatory skin diseases.
Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells are too varied, and the microenvironment is too tumor-friendly. Researchers at the University of Basel and University Hospital Basel have now developed an immunotherapy that not only attacks the tumor—it also turns its microenvironment against it.